Crossmark

Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy

Published Online: 2022-07-01

Published Print: 2022-12

Authors

Vermilyea, Scott C.

Christensen, Anne

Meints, Joyce

Singh, Balvindar

Martell-Martínez, Héctor

Karim, Md. Razaul

Lee, Michael K. http://orcid.org/0000-0001-5865-9682
Funding

Funding for this research was provided by:

National Institute of Neurological Disorders and Stroke (NS108686, NS112540, -NS092093, NS086074)

ASAP/MJFF (ASAP-000592)
License Information

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-07-01
More Information

Article History

Received: 27 December 2021

Accepted: 27 May 2022

First Online: 1 July 2022

Declarations

:

: All experimental protocols involving mice were in strict adherence to the NIH Animal Care and Guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Minnesota. All applicable ethical standards required by University of Minnesota IACUC was followed. All authors declare no conflict of interest.

: Not applicable.

: The authors declare no conflict of interest.

Document is current